S 
Sigma Healthcare SIG.AX · AUD
Health Care · Health Care Providers & Services · ASX · 🇦🇺 Australia
2.85
+1.06%
Close of 9 Nov 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in AUD, from our data supplier.
Revenue
A$10.83bn
FY2017FY2026
Net income
A$709.2m
FY2017FY2026
Free cash flow
A$517.9m
FY2017FY2026
Shareholders' equity
A$5.00bn
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | A$10.83bn | A$4.89bn | A$3.32bn | A$3.66bn | A$3.45bn | A$3.40bn | A$3.24bn | A$3.98bn | A$4.09bn | A$4.37bn |
| Operating income | A$998.0m | A$722.6m | −A$71.9m | −A$68.9m | −A$110.2m | −A$98.4m | −A$101.0m | −A$36.4m | A$83.4m | A$15.2m |
| Net income | A$709.2m | A$529.9m | A$4.5m | A$1.8m | −A$7.2m | A$43.5m | −A$12.3m | A$36.5m | A$55.1m | A$53.2m |
| Diluted earnings per share | 0.06 | 0.05 | 0.00 | 0.00 | -0.00 | 0.00 | -0.00 | 0.00 | 0.01 | 0.00 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | A$8.91bn | A$1.83bn | A$1.40bn | A$1.20bn | A$1.28bn | A$1.22bn | A$1.23bn | A$1.38bn | A$1.30bn | A$1.12bn |
| Cash and short-term investments | A$131.1m | A$14.6m | A$356.5m | A$16.6m | A$31.1m | A$16.1m | A$104.2m | A$72.6m | A$82.2m | A$24.4m |
| Total liabilities | A$3.92bn | A$991.3m | A$531.5m | A$723.8m | A$786.7m | A$705.0m | A$752.7m | A$869.6m | A$789.5m | A$580.3m |
| Debt | A$2.02bn | A$132.1m | A$136.6m | A$227.0m | A$323.4m | A$215.2m | A$300.2m | A$315.8m | A$195.8m | A$33.2m |
| Shareholders' equity | A$5.00bn | A$837.9m | A$870.8m | A$475.9m | A$487.2m | A$513.7m | A$476.0m | A$513.3m | A$513.1m | A$536.8m |
| Shares outstanding | 11,510m | 11,510m | 18,580m | 10,522m | 10,213m | 10,190m | 10,172m | 10,022m | 10,305m | 10,695m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | A$574.6m | A$598.8m | A$42.0m | A$33.4m | A$27.7m | A$12.5m | A$200.6m | A$8.5m | A$71.2m | A$145.8m |
| Capital spending | −A$56.7m | −A$7.9m | −A$4.7m | −A$29.4m | −A$14.2m | −A$77.0m | −A$57.1m | −A$108.2m | −A$62.3m | −A$25.2m |
| Free cash flow | A$517.9m | A$590.9m | A$37.2m | A$4.0m | A$13.5m | −A$64.6m | A$143.5m | −A$99.7m | A$8.9m | A$120.6m |
| Dividends paid | −A$378.8m | −A$17.1m | −A$10.0m | −A$15.9m | −A$19.9m | −A$1.6m | −A$30.7m | −A$41.0m | −A$55.2m | −A$55.7m |
Latest quarters
By quarter end
| Apr 2026 | Oct 2025 | Jun 2025 | Apr 2025 | Jan 2025 | Jul 2024 | Jan 2024 | Jul 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | A$5.33bn | A$5.51bn | A$6.00bn | A$4.04bn | A$3.05bn | A$1.84bn | A$1.64bn | A$1.68bn |
| Operating income | A$454.3m | A$543.7m | A$737.7m | A$307.1m | A$10.2m | −A$20.3m | −A$18.7m | −A$31.1m |
| Net income | A$329.4m | A$379.8m | A$529.9m | A$220.0m | −A$17.6m | A$3.7m | −A$6.7m | A$11.2m |
| Diluted earnings per share | 0.03 | 0.03 | 0.05 | 0.02 | -0.00 | 0.00 | -0.00 | 0.00 |
| Cash from operations | A$257.0m | A$317.0m | — | A$170.0m | −A$208.0m | −A$107.0m | A$43.0m | −A$1.0m |
| Capital spending | −A$33.0m | −A$23.0m | — | −A$23.0m | −A$5.0m | −A$2.0m | −A$3.0m | −A$1.0m |
| Free cash flow | A$224.0m | A$294.0m | — | A$147.0m | −A$213.0m | −A$109.0m | A$40.0m | −A$2.0m |
| Total assets | A$9.34bn | A$8.74bn | A$8.29bn | A$8.29bn | A$1.83bn | A$1.70bn | A$1.40bn | A$1.09bn |
| Cash and short-term investments | A$131.1m | A$163.1m | A$138.8m | A$138.8m | A$14.6m | A$234.2m | A$356.5m | A$11.3m |
| Debt | A$960.1m | A$2.00bn | A$1.88bn | A$2.07bn | A$132.1m | A$137.6m | A$136.6m | A$234.6m |
| Shareholders' equity | A$5.00bn | A$4.90bn | A$4.67bn | A$4.67bn | A$837.9m | A$870.0m | A$870.8m | A$483.9m |
Financial ratios
Data as of 21 Sept 2026
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2012 | FY2010 | FY2009 | FY2008 | FY2007 | FY2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | 9.2% | 0.6% | 0.8% | 0.5% | 0.1% | 1.2% | — | — | — | — | — | — |
| Net margin | 6.5% | -0.3% | 0.1% | 0.0% | -0.2% | 1.3% | — | — | — | — | — | — |
| Return on equity | 14.2% | -1.7% | 0.5% | 0.4% | -1.5% | 8.5% | — | — | — | — | — | — |
| Return on assets | 7.6% | -0.8% | 0.3% | 0.2% | -0.6% | 3.6% | — | — | — | — | — | — |
| Free cash flow yield | 2.2% | -1.1% | 0.1% | 0.2% | 0.2% | 0.3% | — | — | — | — | — | — |
| Revenue growth | 121.4% | 47.3% | -9.2% | 6.2% | 1.3% | 4.8% | — | — | — | — | — | — |
| Earnings growth | -5223.4% | -407.0% | 149.0% | -125.0% | -116.6% | -453.0% | — | — | — | — | — | — |
| Current ratio | 1.67x | 1.59x | 2.46x | 1.44x | 1.66x | 1.34x | — | — | — | — | — | — |
| Debt to equity | 0.19x | 1.03x | 0.01x | 0.20x | 0.39x | 0.15x | — | — | — | — | — | — |
| Equity ratio | 53.5% | 45.8% | 62.0% | 39.6% | 38.2% | 42.1% | — | — | — | — | — | — |
| Interest coverage | 8.74x | 1.60x | 1.53x | 1.38x | 0.23x | 3.42x | — | — | — | — | — | — |
| R&D as a share of sales | — | — | — | — | — | — | 0.0% | 0.2% | 0.2% | 0.2% | 0.1% | 0.5% |
| Buybacks as a share of market value | 0.0% | 38.0% | -76.6% | -3.0% | -0.2% | -0.2% | — | — | — | — | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 43.6% | 26.1% | 12.1% |
| Operating income | — | — | 52.5% |
| Net income | 631.6% | 74.7% | 30.2% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 10.9% | 7.0% | 4.6% | 2.8% |
| Net margin | 7.9% | 5.5% | 4.3% | 3.0% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 45.7 | 64.0 | — | — | -853.5 | 112.4 | -507.4 | 159.2 | 106.7 | 119.2 |
| Price to sales | 3.0 | 6.9 | 14.8 | 2.9 | 1.8 | 1.4 | 1.9 | 1.5 | 1.4 | 1.4 |
Dividends and splits
Per share, in the currency the company pays
Paid for 5 years. Last went ex-dividend on 3 Sept 2026.
| FY2027 | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 0.04 | 0.019 | 0.011 | 0.014 | 0.021 | 0.014 | 0.014 | 0.043 |
- 1-to-1 reverse split · 6 Dec 2005
- 5-for-1 split · 27 Apr 2005
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.